343 related articles for article (PubMed ID: 34819519)
1. Synergistic insights into human health from aptamer- and antibody-based proteomic profiling.
Pietzner M; Wheeler E; Carrasco-Zanini J; Kerrison ND; Oerton E; Koprulu M; Luan J; Hingorani AD; Williams SA; Wareham NJ; Langenberg C
Nat Commun; 2021 Nov; 12(1):6822. PubMed ID: 34819519
[TBL] [Abstract][Full Text] [Related]
2. Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods.
Katz DH; Robbins JM; Deng S; Tahir UA; Bick AG; Pampana A; Yu Z; Ngo D; Benson MD; Chen ZZ; Cruz DE; Shen D; Gao Y; Bouchard C; Sarzynski MA; Correa A; Natarajan P; Wilson JG; Gerszten RE
Sci Adv; 2022 Aug; 8(33):eabm5164. PubMed ID: 35984888
[TBL] [Abstract][Full Text] [Related]
3. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
4. Large-scale plasma proteomics comparisons through genetics and disease associations.
Eldjarn GH; Ferkingstad E; Lund SH; Helgason H; Magnusson OT; Gunnarsdottir K; Olafsdottir TA; Halldorsson BV; Olason PI; Zink F; Gudjonsson SA; Sveinbjornsson G; Magnusson MI; Helgason A; Oddsson A; Halldorsson GH; Magnusson MK; Saevarsdottir S; Eiriksdottir T; Masson G; Stefansson H; Jonsdottir I; Holm H; Rafnar T; Melsted P; Saemundsdottir J; Norddahl GL; Thorleifsson G; Ulfarsson MO; Gudbjartsson DF; Thorsteinsdottir U; Sulem P; Stefansson K
Nature; 2023 Oct; 622(7982):348-358. PubMed ID: 37794188
[TBL] [Abstract][Full Text] [Related]
5. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Proteomic Assessment Methods in Multiple Cohort Studies.
Raffield LM; Dang H; Pratte KA; Jacobson S; Gillenwater LA; Ampleford E; Barjaktarevic I; Basta P; Clish CB; Comellas AP; Cornell E; Curtis JL; Doerschuk C; Durda P; Emson C; Freeman CM; Guo X; Hastie AT; Hawkins GA; Herrera J; Johnson WC; Labaki WW; Liu Y; Masters B; Miller M; Ortega VE; Papanicolaou G; Peters S; Taylor KD; Rich SS; Rotter JI; Auer P; Reiner AP; Tracy RP; Ngo D; Gerszten RE; O'Neal WK; Bowler RP;
Proteomics; 2020 Jun; 20(12):e1900278. PubMed ID: 32386347
[TBL] [Abstract][Full Text] [Related]
7. Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders.
Yang C; Farias FHG; Ibanez L; Suhy A; Sadler B; Fernandez MV; Wang F; Bradley JL; Eiffert B; Bahena JA; Budde JP; Li Z; Dube U; Sung YJ; Mihindukulasuriya KA; Morris JC; Fagan AM; Perrin RJ; Benitez BA; Rhinn H; Harari O; Cruchaga C
Nat Neurosci; 2021 Sep; 24(9):1302-1312. PubMed ID: 34239129
[TBL] [Abstract][Full Text] [Related]
8. Complementarity of SOMAscan to LC-MS/MS and RNA-seq for quantitative profiling of human embryonic and mesenchymal stem cells.
Billing AM; Ben Hamidane H; Bhagwat AM; Cotton RJ; Dib SS; Kumar P; Hayat S; Goswami N; Suhre K; Rafii A; Graumann J
J Proteomics; 2017 Jan; 150():86-97. PubMed ID: 27613379
[TBL] [Abstract][Full Text] [Related]
9. A genome-wide association study of mass spectrometry proteomics using the Seer Proteograph platform.
Suhre K; Chen Q; Halama A; Mendez K; Dahlin A; Stephan N; Thareja G; Sarwath H; Guturu H; Dwaraka VB; Batzoglou S; Schmidt F; Lasky-Su JA
bioRxiv; 2024 Jun; ():. PubMed ID: 38853852
[TBL] [Abstract][Full Text] [Related]
10. High-Throughput Characterization of Blood Serum Proteomics of IBD Patients with Respect to Aging and Genetic Factors.
Di Narzo AF; Telesco SE; Brodmerkel C; Argmann C; Peters LA; Li K; Kidd B; Dudley J; Cho J; Schadt EE; Kasarskis A; Dobrin R; Hao K
PLoS Genet; 2017 Jan; 13(1):e1006565. PubMed ID: 28129359
[TBL] [Abstract][Full Text] [Related]
11. Beyond antibodies: new affinity reagents to unlock the proteome.
Lollo B; Steele F; Gold L
Proteomics; 2014 Mar; 14(6):638-44. PubMed ID: 24395722
[TBL] [Abstract][Full Text] [Related]
12. Trait Loci Mapping and CSF Proteome.
Sasayama D; Hattori K; Kunugi H
Methods Mol Biol; 2019; 2044():365-376. PubMed ID: 31432426
[TBL] [Abstract][Full Text] [Related]
13. The genetic regulation of protein expression in cerebrospinal fluid.
Hansson O; Kumar A; Janelidze S; Stomrud E; Insel PS; Blennow K; Zetterberg H; Fauman E; Hedman ÅK; Nagle MW; Whelan CD; Baird D; Mälarstig A; Mattsson-Carlgren N
EMBO Mol Med; 2023 Jan; 15(1):e16359. PubMed ID: 36504281
[TBL] [Abstract][Full Text] [Related]
14. Quantitative selection and parallel characterization of aptamers.
Cho M; Soo Oh S; Nie J; Stewart R; Eisenstein M; Chambers J; Marth JD; Walker F; Thomson JA; Soh HT
Proc Natl Acad Sci U S A; 2013 Nov; 110(46):18460-5. PubMed ID: 24167271
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study.
Rooney MR; Chen J; Ballantyne CM; Hoogeveen RC; Tang O; Grams ME; Tin A; Ndumele CE; Zannad F; Couper DJ; Tang W; Selvin E; Coresh J
Clin Chem; 2023 Jan; 69(1):68-79. PubMed ID: 36508319
[TBL] [Abstract][Full Text] [Related]
16. Plasma proteomic associations with genetics and health in the UK Biobank.
Sun BB; Chiou J; Traylor M; Benner C; Hsu YH; Richardson TG; Surendran P; Mahajan A; Robins C; Vasquez-Grinnell SG; Hou L; Kvikstad EM; Burren OS; Davitte J; Ferber KL; Gillies CE; Hedman ÅK; Hu S; Lin T; Mikkilineni R; Pendergrass RK; Pickering C; Prins B; Baird D; Chen CY; Ward LD; Deaton AM; Welsh S; Willis CM; Lehner N; Arnold M; Wörheide MA; Suhre K; Kastenmüller G; Sethi A; Cule M; Raj A; ; ; ; ; ; ; ; ; ; Burkitt-Gray L; Melamud E; Black MH; Fauman EB; Howson JMM; Kang HM; McCarthy MI; Nioi P; Petrovski S; Scott RA; Smith EN; Szalma S; Waterworth DM; Mitnaul LJ; Szustakowski JD; Gibson BW; Miller MR; Whelan CD
Nature; 2023 Oct; 622(7982):329-338. PubMed ID: 37794186
[TBL] [Abstract][Full Text] [Related]
17. Proteogenomic links to human metabolic diseases.
Koprulu M; Carrasco-Zanini J; Wheeler E; Lockhart S; Kerrison ND; Wareham NJ; Pietzner M; Langenberg C
Nat Metab; 2023 Mar; 5(3):516-528. PubMed ID: 36823471
[TBL] [Abstract][Full Text] [Related]
18. Connecting genetic risk to disease end points through the human blood plasma proteome.
Suhre K; Arnold M; Bhagwat AM; Cotton RJ; Engelke R; Raffler J; Sarwath H; Thareja G; Wahl A; DeLisle RK; Gold L; Pezer M; Lauc G; El-Din Selim MA; Mook-Kanamori DO; Al-Dous EK; Mohamoud YA; Malek J; Strauch K; Grallert H; Peters A; Kastenmüller G; Gieger C; Graumann J
Nat Commun; 2017 Feb; 8():14357. PubMed ID: 28240269
[TBL] [Abstract][Full Text] [Related]
19. Characterizing the Causal Pathway for Genetic Variants Associated with Neurological Phenotypes Using Human Brain-Derived Proteome Data.
Kibinge NK; Relton CL; Gaunt TR; Richardson TG
Am J Hum Genet; 2020 Jun; 106(6):885-892. PubMed ID: 32413284
[TBL] [Abstract][Full Text] [Related]
20. Linking protein to phenotype with Mendelian Randomization detects 38 proteins with causal roles in human diseases and traits.
Bretherick AD; Canela-Xandri O; Joshi PK; Clark DW; Rawlik K; Boutin TS; Zeng Y; Amador C; Navarro P; Rudan I; Wright AF; Campbell H; Vitart V; Hayward C; Wilson JF; Tenesa A; Ponting CP; Baillie JK; Haley C
PLoS Genet; 2020 Jul; 16(7):e1008785. PubMed ID: 32628676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
